Could This COVID Anti-Viral Pill Fuel the Emergence of New Variants?

Molnupiravir was authorized for emergency use in the U.S. in December 2021 as other experts downplayed fears.

Related Keywords

Meharry Medical College ,Tennessee ,United States ,John Williams ,Sankar Swaminathan ,Ridgeback Biotherapeutics ,William Haseltine ,Michael Lin ,Douglas Richman ,James Hildreth ,University Of Pittsburgh School Medicine ,Drug Administration ,Harvard Medical School ,Pfizer ,University Of Utah School Medicine ,University Of California San Diego ,Stanford University ,California San Diego ,Pittsburgh School ,Utah School ,Health ,Health And Medicine ,Coronavirus ,Drugs ,Infectious Diseases ,Antiviral ,Merck ,Pandemics ,Molnupiravir ,Covid 19 ,